ClosedPublished 30 Oct 2025

Bluefin Merger Subsidiary, Inc. /
89bio

Roche subsidiary completes acquisition of 89bio

Buy side: Bluefin Merger Subsidiary, Inc.
Buy sideBluefin Merger Subsidiary, Inc.
Target: 89bio
Target89bio
Roche Holdings, Inc. · 30 Oct 2025Source
Buy side: Bluefin Merger Subsidiary, Inc.
Buy sideBluefin Merger Subsidiary, Inc.
Target: 89bio
Target89bio
01 / BuyerBluefin Merger Subsidiary, Inc.
02 / Target89bio
Source for the buyer and target: Roche Holdings, Inc.

For the buyer and target.

“Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that Roche’s wholly owned subsidiary Bluefin Merger Subsidiary, Inc., has accepted for payment all shares validly tendered and not validly withdrawn pursuant to its tender offer for all outstanding shares of common stock of 89bio, Inc. (“89bio”, NASDAQ: ETNB) at a price of $14.50 per share in cash, plus a non-tradeable contingent value right (CVR) to receive certain milestone payments of up to an aggregate of $6.00 per share in cash.”

Published 30 Oct 2025

Open the source
01

What happened

Bluefin Merger Subsidiary, Inc. completed its acquisition of 89bio, Inc. through a merger, following the tender offer for the company’s shares. [01]

The offer provided $14.50 per share in cash, plus a contingent value right for milestone payments of up to $6.00 per share. 89bio is a clinical-stage biopharmaceutical company developing therapies for liver and cardiometabolic diseases. [01]

02

Who is involved, and the source

Everything on this page comes from the source below, quoted word for word.

Advisers

Target

Each adviser in its source's own words. An adviser's own announcement is labelled as one: it is not independent reporting. Advisers are not parties to the deal.

01
Source · Roche Holdings, Inc.

Roche subsidiary completes acquisition of 89bio

This document is the source for the companies, stage, figure and people on this page.

Open the source
03

Timeline

Every date the source states, in order, each with the words it comes from. Anything marked ahead is a target the source gives, not something that has happened.

  1. Published by Roche Holdings, Inc.

    The source this page is built from.

    Open the source

The same firms, in other deals

The firms' deal history and connections across other deals.

These firms' full profiles are part of Pro.

Get ProAlready a member? Sign in

Pro is open to everyone.